Forxiga 10 mg film-coated tablets, Balcinrenone+Dapagliflozin, Balcinrenone+Dapagliflozin, Balcinrenone+Dapagliflozin, Forxiga
D6405C00002
Phase 2 small_molecule active
Quick answer
Forxiga 10 mg film-coated tablets, Balcinrenone+Dapagliflozin, Balcinrenone+Dapagliflozin, Balcinrenone+Dapagliflozin, Forxiga for Chronic Kidney Disease and Albuminuria is a Phase 2 program (small_molecule) at AstraZeneca AB with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca AB
- Indication
- Chronic Kidney Disease and Albuminuria
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active